New strategies for noninvasive screening and prenatal diagnosis: The cell-free fetal DNA in maternal blood;Nuove frontiere nello screening e nella diagnostica prenatale non invasiva: Il DNA fetale circolante nel sangue materno

Minerva Ginecologica

Volumn 59, Issue 3, 2007, Pages 331-341

  Montagnana, M ^a,b   Lippi, G ^a   Guidi, G C ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Fetal stem cells; Pregnancy; Prenatal diagnosis

Indexed keywords

DNA;

ANEUPLOIDY; CYSTIC FIBROSIS; GENDER; HUMAN; MATERNAL BLOOD; NON INVASIVE PROCEDURE; PREGNANT WOMAN; PRENATAL DIAGNOSIS; REVIEW; TRISOMY 13; TRISOMY 18; TRISOMY 21; X CHROMOSOME LINKED DISORDER;

ANEUPLOIDY; CYSTIC FIBROSIS; DNA; DOWN SYNDROME; FEMALE; FETAL DISEASES; FETAL STEM CELLS; FETUS; GENETIC DISEASES, INBORN; GENETIC DISEASES, X-LINKED; GENOTYPE; HUMANS; MASS SCREENING; MOTHERS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 34547633061     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (94)

1. Brambati B, Tului L. Chorionic villus sampling and amniocentesis. Curr Opin Obstet Gynecol 2005;17:197-201.
2. Eisenberg B, Wapner RJ. Clinical proceduress in prenatal diagnosis. Best Pract Res Clin Obstet Gynaecol 2002;16:611-27.
3. Wilson RD. Amniocentesis and chorionic villus sampling. Curr Opin Obstet Gynecol 2000;12:81-6.
4. Tercyak KP, Johnson SB, Roberts SF, Cruz AC. Psychological response to prenatal genetic counseling and amniocentesis. Patient Educ Couns 2001;43:73-84.
5. Bischoff FZ, Lewis DE, Simpson JL. Cell-free fetal DNA in maternal blood: kinetics, source and structure. Hum Reprod Update 2005;11:59-67.
6. Bianchi DW, Simpson JL, Jackson LG, Elias S, Holzgreve W, Evans MI et al. Fetal gender and aneuploidy detection using fetal cells in maternal blood: Analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn 2002;22:609-15.
7. Holzgreve W, Garritsen HS, Ganshirt-Ahlert D. Fetal cells in the maternal circulation. J Reprod Med 1992;37:410-8.
8. Hamada H, Arinami T, Kubo T, Hamaguchi, Iwasaki H. Fetal nucleated cells in maternal peripheral blood: frequency and relationship to gestational age. Hum Genet 1993;91:427-32.
9. Lam NY, Rainer TH, Chiu RW, Lo YM. EDTA is a better anticoagulant than heparin or citrate for delayed blood processing for plasma DNA analysis. Clin Chem 2004;50:256-7.
10. Pongsritasana T, Wongratanacheewin S, Prasertcharoensuk V, Sermswan RW. Isolation of fetal nucleated red blood cell from maternal blood using immunomagnetic beads for prenatal diagnosis. Asian Pac J Allergy Immunol 2006;24:65-71.
11. Ganshirt D, Smeets FW, Dohr A, Walde C, Steen I, Lapucci C et al. Enrichment of fetal nucleated red blood cells from the maternal circulation for prenatal diagnosis: experiences with triple density gradient and MACS based on more than 600 cases. Fetal Diagn Ther 1998;13:276-86.
12. Tutschek B, Reinhard J, Kogler G, Wernet P, Niederacher D. Clonal culture of fetal cells from maternal blood. Lancet 2000;356:1736-7.
13. Bischoff FZ, Hahn S, Johnson KL, Simpson JL, Bianchi DW, Lewis DE et al. Intact fetal cells in maternal plasma: are they really there? Lancet 2003;361:139-40.
14. Lo YM, Poon LL. The ins and outs of fetal DNA in maternal plasma. Lancet 2003;361:193-4.
15. Valerio D, Aiello R, Altieri V. Isolation of fetal erythroid cells from maternal blood based on expression of erythropoietin receptors. Mol Hum Reprod 1997;3:451-5.
16. Sohda S, Arinami T, Hamada H, Nakauchi H, Hamaguchi H, Kubo T. The proportion of fetal nucleated red blood cells in maternal blood: estimation by FACS analysis. Prenat Diagn 1997;17:743-52.
17. Little MT, Langlois S, Wilson RD, Lansdorp PM. Frequency of fetal cells in sorted subpopulations of nucleated erythroid and CD341 hematopoietic progenitor cells from maternal peripheral blood. Blood 1997;89:2347-58.
18. Bianchi DW, Hanson J. Sharpening the Tools: A summary of a National Institutes of Health workshop on new technologies for detection of fetal cells in maternal blood for early prenatal diagnosis. J Matern Fetal Neonatal Med 2006;19:199-207.
19. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A 1996;93:705-8.
20. Purwosunu Y, Sekizawa A, Farina A, Okai T, Takabayashi H, Wen P et al. Enrichment of NRBC in maternal blood: a more feasible method for noninvasive prenatal diagnosis. Prenat Diagn 2006;26:545-7.
21. Choe J, Hwang D, Kim KC, Choi YM. Fetal gender determination and BclI polymorphism using nucleated erythrocytes in maternal blood. J Histochem Cytochem 2005;53:323-7.
22. Saker A, Benachi A, Bonnefont JP, Munnich A, Dumez Y, Lacour B et al. Genetic characterisation of circulating fetal cells allows non-invasive prenatal diagnosis of cystic fibrosis. Prenat Diagn 2006;26:906-16.
23. Zhong XY, Holzgreve W, Hahn S. Direct quantification of fetal cells in maternal blood by real-time PCR. Prenat Diagn 2006;26:850-4.
24. Krabchi K, Gadji M, Samassekou O, Gregoire MC, Forest JC, Drouin R. Quantification of fetal nucleated cells in maternal blood of pregnant women with a male trisomy 21 fetus using molecular cytogenetic techniques. Prenat Diagn 2006;26:28-34.
25. Lo YMD, Corbetta N, Chamberlain PF, Rai V, Sargetn IL, Redman CW et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-7.
26. Bianchi DW. Circulating fetal DNA: its origin and diagnostic potential - A review. Placenta 2004;25:S93-S101.
27. Lo YMD, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768-75.
28. Poon LL, Leung TN, Lau TK, Lo YM. Presence of fetal RNA in maternal plasma. Clin Chem 2000;46:1832-4.
29. Poon LL, Leung TN, Lau TK, Lo YM. Circulating fetal RNA in maternal plasma. Ann N Y Acad Sci 2001;945:207-10.
30. Honda H, Miharu N, Ohashi Y, Samura O, Kinutani M, Hara T et al. Fetal gender determination in early pregnancy through qualitative and quantitative analysis of fetal DNA in maternal serum. Hum Genet 2002;110:75-9.
31. Guibert J, Benachi A, Grebille AG, Ernault P, Zorn JR, Costa JM. Kinetics of SRY gene appearance in maternal serum: detection by real time PCR in early pregnancy after assisted reproductive technique. Hum Reprod 2003;18:1733-6.
32. Birch L, English CA, O'Donoghue K, Barigye O, Fisk NM, Keer JT. Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation. Clin Chem 2005;51:312-20.
33. Bianchi DW. Fetal cells in the mother: from genetic diagnosis to diseases associated with fetal cell micro-chimerism. Eur J Obstet Gynecol Reprod Biol 2000;92:103-8.
34. Chan LY, Leung TN, Chan KC, Tai HL, Lau TK, Wong EM et al. Serial analysis of fetal DNA concentrations in maternal plasma in late pregnancy. Clin Chem 2003;49:678-80.
35. Ohashi Y, Miharu N, Honda H, Samura O, Ohama K. Correlation of fetal DNA and human chorionic gonadotropin concentrations in second-trimester maternal serum. Clin Chem 2002;48:386-8.
36. Sekizawa A, Kondo T, Iwasaki M, Watanabe A, Jimbo M, Saito H et al. Accuracy of fetal gender determination by analysis of DNA in maternal plasma. Clin Chem 2001;47:1856-8.
37. Angert RM, LeShane ES, Lo YM, Chan LY, Delli-Bovi LC, Bianchi DW. Fetal cell-free plasma DNA concentrations in maternal blood are stable 24 hours after collection: analysis of first- and third trimester samples. Clin Chem 2003;49;195-8.
38. Lo YMD, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999;64:218-24.
39. Martinhago CD, de Oliveira RM, Tomitao Canas MD, Vagnini LD, Alcantara Oliveira JB, Petersen CG et al. Accuracy of fetal gender determination in maternal plasma at 5 and 6 weeks of pregnancy. Prenat Diagn 2006;26:1219-23.
40. Lagona F, Smid M, Papasergio N, Ferrari A, Ferrari M, Cremonesi L. Multiple testing in fetal gender determination from maternal blood by polymerase chain reaction. Hum Genet 1998;102:687-90.
41. Honda H, Miharu N, Ohashi Y, K Ohama. Successful diagnosis of fetal gender using conventional per analysis of maternal serum. Clin Chem 2001;47:41-6.
42. Tungwiwat W, Fucharoen G, Ratanasiri T, Sanchaisuriya K, Fucharoen S. Non-invasive fetal sex determination using a conventional nested PCR analysis of fetal DNA in maternal plasma. Clin Chim Acta 2003;334:173-7.
43. Hwa HL, Ko TM, Yen ML, Chiang YL. Fetal gender determination using real-time quantitative polymerase chain reaction analysis of maternal plasma Formos Med Assoc 2004;103:364-8.
44. Zolotukhina TV, Shilova NV, Voskoboeva EY. Analysis of cell-free fetal DNA in plasma and serum of pregnant women. J Histochem Cytochem 2005;53:297-9.
45. Davalieva K, Dimcev P, Efremov GD, Plaseska-Karanfilska DJ. Non-invasive fetal sex determination using real-time PCR. Matern Fetal Neonatal Med 2006;19:337-42.
46. Baird PA, Anderson TW, Newcombe HB, Lowry RB. Genetic disorders in children and young adults: a population study. Am J Hum Genet 1988;42:677-93.
47. Hyett JA, Gardener G, Stojilkovic-Mikic T, Finning KM, Martin PG, Rodeck CH et al. Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy. Prenat Diagn 2005;25:1111-6.
48. Rijnders RJ, van der Schoot CE, Bossers B, de Vroede MA, Christaens CJ. Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia. Obstet Gynecol 2001;98:374-8.
49. Bianchi DW. Prenatal exclusion of recessively inherited disorders: should maternal plasma analysis precede invasive techniques? Clin Chem 2002;48:689-90.
50. Mazza V, Falcinelli C, Percesepe A, Paganelli S, Volpe A, Forabosco A. Non-invasive first trimester fetal gender assignement in pregnancies at risk for X-linked recessive diseases. Prenat Diagn 2002;22:919-24.
51. Zhong XY, Holzgreve W, Hahn S. Detection of fetal Rheus D and sex using fetal DNA from maternal plasma by multiplex polymerase chain reaction. BJOG 2000;107:766-79.
52. Bischoff FZ, Nguyen DD, Marquez-Do D, Moise KJ Jr, Simpson JL, Elias S. Noninvasive determination of fetal RhD status using fetal DNA in maternal serum and PCR. J Soc Gynecol Investig 1999;6:64-9.
53. Daniels G, Finning K, Martin P, Summers J. Fetal blood group genotyping: present and future. Ann N Y Acad Sci 2006;1075:88-95.
54. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-73.
55. Buchwald M, Tsui LC, Riordan JR. The search for the cystic fibrosis gene. Am J Physiol 1989;257:L47-52.
56. Gonzàlez-Gonzàlez MC, Garcìa-Hoyos M, Trujillo MJ, Rodrìguez de Alba M, Lorda-Sànchez I, Dìaz-Recasens J et al. Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenat Diagn 2002;22:946-8.
57. Nasis O, Thompson S, Hong T, Sherwood M, Radcliffe S, Jackson L, Otevrel T. Improvement in sensitivity of allele-specific PCR facilitates reliable noninvasive prenatal detection of cystic fibrosis. Clin Chem 2004,50:694-701.
58. Zhu B, Sun QW, Lu YC, Sun MM, Wang LJ, Huang XH. Prenatal fetal sex diagnosis by detecting amelogenin gene in maternal plasma. Prenat Diagn 2005;25:577-81.
59. Santacroce R, Vecchione G, Tomaiyolo M, Sessa F, Sarno M, Colaizzo D et al. Identification of fetal gender in maternal blood is a helpful tool in the prenatal diagnosis of haemophilia. Haemophilia 2006;12:417-22.
60. Chi C, Hyett JA, Finning KM, Lee CA, Kadir RA. Noninvasive first trimester determination of fetal gender: a new approach for prenatal diagnosis of haemophilia. BJOG 2006;113:239-42.
61. Chiu RWK, Lau TK, Leung TN, Chow KCK, Chui DHK, Lo YM. Prenatal exclusion of beta-thalassaemia major by examination of maternal plasma. Lancet 2002;360:998-1000.
62. Li Y, Di Naro E, Vitucci A, Zimmermann B, Holzgreve W, Hahn S. Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA 2005;293:843-9.
63. Winichagoon P, Sithongdee S, Kanokpongsakdi S, Tantisirin P, Bernini LF, Fucharoen S. Noninvasive prenatal diagnosis for hemoglobin Bart's hydrops fetalis. Int J Hematol 2005;81:396-9.
64. Chiu RWK, Lau TK, Cheung PT, Gong ZQ, Leung TN, Lo YMD. Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study. Clin Chem 2002;48:778-80.
65. New MI, Carlson A, Obeid J, Marshall I, Cabrera MS, Goseco A et al. Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J Clin Endocrinol Metab 2001;86:5651-7.
66. Lo YMD, Lau TK, Zhang J, Leung TN, Chang AM, Hjelm N et al. Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clin Chem 1999;45:1747-51.
67. Farina A, LeShane ES, Lambert-Messerlian GM, Canick JA, Lee T, Neveux LM et al. Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy. Clin Chem 2003;49:239-42.
68. Lee T, LeShane ES, Messerlian GM, Canick JA, Farina A, Heber WW et al. Down syndrome and cell-free fetal DNA in archived maternal serum. Am J Obstet Gynecol 2002;187:1217-21.
69. Poon LL, Leung TN, Lau TK, Lo YM. Prenatal detection of fetal Down's syndrome from maternal plasma. Lancet 2000;356:1819-20.
70. Brook JD, McCurrach ME, Harley HG, Bucler AJ, Church D, Aburatani H et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 39 end of a transcript encoding a protein kinase family member. Cell 1992;68:799-808.
71. Amicucci P, Gennarelli M, Novelli G, Dalla piccola B. Prenatal diagnosis of myotonic dystrophy using fetal dna obtained from maternal plasma. Clin Chem 2000;46:301-2.
72. Gonzalez-Gonzalez MC, Trujillo MJ, Rodriguez de Alba M, Ramos C. Early Huntington disease prenatal diagnosis by maternal semiquantitative fluorescent-PCR. Neurology 2003;60:1214-5.
73. Lo YM, Leung TN, Tein MS, Sargent IL, Zhang J, Lau TK et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999;45:184-8.
74. Zhong XY, Laivuori H, Livingston JC, Ylikorkala O, Sibai BM, Holzgreve W et al. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol 2001;184:414-9.
75. Lau TW, Leung TN, Chan LY, Lau TK, Chan KC, Tam WH et al. Fetal DNA clearance from maternal plasma is impaired in preeclampsia. Clin Chem 2002;48:2141-6.
76. Farina A, Sekizawa A, Purwosunu Y, Rizzo N, Banzola I, Concu M et al. Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls. Prenat Diagn 2006;26:1115-20.
77. Koide K, Sekizawa A, Iwasaki M, Matsuoka R, Honma S, Farina A et al. Fragmentation of cell-free fetal DNA in plasma and urine of pregnant women. Prenat Diagn 2005;25:604-7.
78. Farina A, Sekizawa A, Iwasaki M, Matsuoka R, Ichizuka K, Okai T. Total cell-free DNA (beta-globin gene) distribution in maternal plasma at the second trimester: a new prospective for preeclampsia screening. Prenat Diagn 2004;24:722-6.
79. Farina A, Sekizawa A, Sugito Y, Iwasaki M, Jimbo M, Saito H et al. Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk non-symptomatic patients. Prenat Diagn 2004;24:83-6.
80. Smid M, Vassallo A, Lagona F, Valsecchi L, Maniscalco L, Danti L et al. Quantitative analysis of fetal DNA in maternal plasma in pathological conditions associated with placental abnormalities. Ann N Y Acad Sci 2001;945:132-7.
81. Sekizawa A, Farina A, Koide K, Iwasaki M, Honma S, Ichizuka K et al. Beta-globin DNA in maternal plasma as a molecular marker of pre-eclampsia. Prenat Diagn 2004;24:697-700.
82. Sekizawa A, Jimbo M, Saito H, Iwasaki M, Matsuoka R, Okai T et al. Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction. Am J Obstet Gynecol 2003;188:480-4.
83. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, increased liver enzymes and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993;169:1000-6.
84. Swinkels DW, de Kok JB, Hendriks JCM, Wiegerinck E, Zusterzee PLM, Steegers EAP. Hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal DNA in maternal plasma and serum. Clin Chem 2002;48:650-3.
85. Caramelli E, Rizzo N, Concu M, Simonazzi G, Carinci P, Bondavalli C et al. Cell-free fetal DNA concentration in plasma of patients with abnormal uterine artery Doppler waveform and intrauterine growth restriction - a pilot study. Prenat Diagn 2003;23:367-71.
86. Leung TN, Zhang J, Lau TK, Hjelm NM, Lo YMD. Maternal plasma fetal DNA as a marker for preterm labour. Lancet 1998;352:1904-5.
87. Sekizawa A, Jimbo M, Saito H, Iwasaki M, Sugito Y, Yukimoto Y et al. Increased cell-free fetal DNA in plasma of two women with invasive placenta. Clin Chem 2002;48:353-4.
88. Minagawa M, Narita J, Tada T, Maruyama S, Shimizu T, Bannai M et al. Mechanisms underlying immunologic states during pregnancy: possibile association of the sympathetic nervous system. Cell Immunol 1999;196:1-13.
89. Sugito Y, Sekizawa A, Farina A, Yukimoto Y, Saito H, Iwasaki M et al. Relationship between severity of hyperemesis gravidarum and fetal DNA concentration in maternal plasma. Clin Chem 2003;49:1667-9.
90. Lau TK, Stock A, Rogers M. Fetomaternal haemorrhage after external cephalic version at term. Aust N Z J Obstet Gynaecol 1995;35:173-4.
91. Lau TK, Lo KW, Chan LY, Leung TY, Lo YM. Cell-free fetal deoxyribonucleic acid in maternal circulation as a marker of fetal-maternal hemorrhage in patients undergoing external cephalic version near term. Am J Obstet Gynecol 2000;183:712-6.
92. Zhong XY, Holzgreve W, Li JC, Aydinli K, Hahn S. High levels of fetal erythroblasts and fetal extracellular DNA in the peripheral blood of a pregnant woman with idiopathic polyhydramnios: case report. Prenat Diagn 2000;20:838-41.
93. Wataganara T, Chen AY, LeShane ES, Sullivan LM, Borgatta L, Bianchi DW et al. Cell-free fetal DNA levels in maternal plasma after elective first trimester termination of pregnancy. Fertil Steril 2004;8:639-44.
94. Wataganara T, Chen AY, LeShane ES, Sullivan LM, Borgatta L, Bianchi DW et al. Changes of cell-free fetal DNA in maternal plasma after elective termination of pregnancy. Clin Chem 2005;55:217-9.